跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - TGA Drug Approval Details
Approvals
/
TGA
/
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Approved
STANDARD
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d7aec6a501ff7463
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d7aec6a501ff7463
Product Name
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Artg Id
312686
Artg Name
Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2018-12-19
Registration Type
Biological
Therapeutic Good Type
Biological
Licence Status
A
Licence Category
INC
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-02121-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-02122-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d7aec6a501ff7463
Type
Standard
Back to TGA Approvals